Description
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser--or aspire to be one--then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs.
THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.
- Vetted benchmarks for key drivers of income, expenses, and valuation.
- Proprietary analyses by Pharmagellan's experienced consulting team.
- More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.
Whether you're making investment decisions, pitching to potential partners or funders, or assessing your own R&D program, this is the one-stop guide you need by your side.
Author: Frank S. David, Seth Robey, Andrew Matthews
Publisher: Pharmagellan, LLC
Published: 01/06/2017
Pages: 138
Binding Type: Paperback
Weight: 0.47lbs
Size: 9.00h x 6.00w x 0.32d
ISBN13: 9780998407500
ISBN10: 099840750X
BISAC Categories:
- Business & Economics | Forecasting
- Business & Economics | Corporate Finance | Valuation
- Business & Economics | Industries | Pharmaceutical & Biotechnology
This title is not returnable